HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis.

AbstractBACKGROUND:
Previous clinical evidence correlates levels of von Willebrand factor (VWF) and its cleaving protease ADAMTS13 with outcome in septic patients. No previous studies addressed if VWF and ADAMTS13 affected the outcome of Staphylococcus aureus sepsis.
OBJECTIVES:
We studied the role of VWF and ADAMTS13 in S. aureus sepsis both in patients and in mice.
METHODS:
VWF levels and ADAMTS13 activity levels were measured in plasma samples from 89 S. aureus bacteremia patients by chemiluminescent assays and were correlated with clinical sepsis outcome parameters. In wild-type mice and mice deficient in VWF and ADAMTS13, we investigated the outcome of S. aureus sepsis and quantified bacterial clearance and organ microthrombi.
RESULTS:
In patients with S. aureus bloodstream infections, high VWF levels and low ADAMTS13 activity levels correlated with disease severity and with parameters of inflammation and disseminated intravascular coagulation. In septic mice, VWF deficiency attenuated mortality, whereas ADAMTS13 deficiency increased mortality. Bacterial clearance was enhanced in VWF-deficient mice. The differences in mortality for the studied genotypes were associated with differential loads of organ microthrombi in both liver and kidneys.
CONCLUSIONS:
In conclusion, this study reports the consistent relation of VWF, ADAMTS13 and their ratio to disease severity in patients and mice with S. aureus sepsis. Targeting VWF multimers and/or the relative ADAMTS13 deficiency that occurs in sepsis should be explored as a potential new therapeutic target in S. aureus endovascular infections.
AuthorsMarijke Peetermans, Severien Meyers, Laurens Liesenborghs, Karen Vanhoorelbeke, Simon F De Meyer, Christophe Vandenbriele, Marleen Lox, Marc F Hoylaerts, Kimberly Martinod, Marc Jacquemin, Thomas Vanassche, Peter Verhamme
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 18 Issue 3 Pg. 722-731 (03 2020) ISSN: 1538-7836 [Electronic] England
PMID31758651 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 International Society on Thrombosis and Haemostasis.
Chemical References
  • von Willebrand Factor
  • ADAMTS13 protein, mouse
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
Topics
  • ADAMTS13 Protein (genetics)
  • Animals
  • Bacteremia (mortality)
  • Humans
  • Mice
  • Sepsis (mortality)
  • Staphylococcal Infections (mortality)
  • Staphylococcus aureus
  • von Willebrand Factor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: